(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory...
Stats | |
---|---|
Dagens volum | 33.00 |
Gjennomsnittsvolum | 12 280.00 |
Markedsverdi | 307.68M |
EPS | $0.220 ( 2023-11-14 ) |
Neste inntjeningsdato | ( $0 ) 2024-06-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 5.35 |
ATR14 | $0 (0.00%) |
Procaps Group S.A. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
PIII | 0.974 |
CREG | 0.965 |
PCSA | 0.96 |
SNPX | 0.959 |
NCBS | 0.959 |
MTP | 0.959 |
LGMK | 0.959 |
NAKD | 0.957 |
PLIN | 0.957 |
UTME | 0.956 |
10 Mest negative korrelasjoner | |
---|---|
PROF | -0.973 |
ARTEU | -0.97 |
ACLS | -0.969 |
JMAC | -0.967 |
CFFE | -0.965 |
BRAC | -0.965 |
GENQ | -0.963 |
FMIV | -0.961 |
AHRN | -0.961 |
HERA | -0.96 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Procaps Group S.A. Økonomi
Annual | 2022 |
Omsetning: | $409.92M |
Bruttogevinst: | $239.57M (58.44 %) |
EPS: | $0.420 |
FY | 2022 |
Omsetning: | $409.92M |
Bruttogevinst: | $239.57M (58.44 %) |
EPS: | $0.420 |
Financial Reports:
No articles found.
Procaps Group S.A.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.